Medicure (MCUJF) Net Income towards Common Stockholders (QoQ) (2009 - 2026)
Medicure (MCUJF) Net Income towards Common Stockholders (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Medicure | 8.77 Mn | 7.64 Mn | 2.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 95.72% |
| Dec 31, 2025 | -582.53% |
| Sep 30, 2025 | -78.82% |
| Jun 30, 2025 | -231.71% |
| Mar 31, 2025 | 208.80% |
| Dec 31, 2024 | -179.41% |
| Sep 30, 2024 | 156.02% |
| Jun 30, 2024 | -2,450.99% |
| Mar 31, 2024 | 103.33% |
| Dec 31, 2023 | -1,915.88% |
| Sep 30, 2023 | -66.73% |
| Jun 30, 2023 | -6.39% |
| Mar 31, 2023 | -94.94% |
| Dec 31, 2022 | 110.80% |
| Sep 30, 2022 | 231.56% |
| Jun 30, 2022 | 102.90% |
| Sep 30, 2021 | -599.94% |
| Jun 30, 2021 | -50.78% |
| Mar 31, 2021 | 111.56% |
| Dec 31, 2020 | -811.55% |